We are live on ! Find out more
THTX

Theratechnologies

Delisted

THTX was delisted on the 25th of September, 2025.

10 hedge funds and large institutions have $5.9M invested in Theratechnologies in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

22.17% less ownership

Funds ownership: 25.96%3.79% (-22%)

79% less capital invested

Capital invested by funds: $28.2M → $5.9M (-$22.3M)

80% less funds holding

Funds holding: 4910 (-39)

93% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 41

Holders
10
Holders Change
-39
Holders Change %
-79.59%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
2
Closed
41
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TC
51
Truvestments Capital
Florida
-$703 -298 Closed

THTX Hedge Fund Activity: Q3 2025 in Review

10 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Theratechnologies (THTX) for Q3 2025, worth a combined $5.9M — down 79% from $28.2M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of THTX and 3 opened new positions — a net loss of 38 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was JBF Capital, opening a new position worth an estimated $2.71M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $11.3M sold.

  • 10 institutional investors held Theratechnologies (THTX) as of Q3 2025, down from 49 in Q2 2025.
  • Funds reported $5.9M of Theratechnologies stock for Q3 2025, down 79% quarter-over-quarter.
  • 3 funds opened new Theratechnologies positions in Q3 2025 and 41 closed out, a net change of -38 holders.
  • The largest Theratechnologies buyer in Q3 2025 was JBF Capital, an estimated $2.71M added.
  • The largest Theratechnologies seller in Q3 2025 was Soleus Capital Management, an estimated $11.3M sold.

Based on aggregated 13F filings for Q3 2025.